http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101330626-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-565 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-565 |
| filingDate | 2005-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101330626-B1 |
| titleOfInvention | Deamidated Interferon-beta |
| abstract | The asparagine deamidated interferon-β protein analogue at position 25 numbered according to native interferon-β shows increased biological activity of native human interferon-β and does not require HA for protein stabilization. Deamidated products are suitable for large scale preparation for incorporation into HA-containing or HA-free therapeutics for the treatment of diseases including multiple sclerosis. In addition, endoproteinase-C peptide map technology, which produces enzyme fingerprinting followed by RP-HPLC to produce a fingerprint profile of the protein, provides quality control such as ID and / or quantitative testing for deamidated products. Useful for n n Interferon-β, deamidation, multiple sclerosis, HA. |
| priorityDate | 2004-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 68.